12 results
management dka comparison diagnosis dm2 hypoglycemia medications agonists anaphylaxis baqsimi ddxof diabetic diabeticketoacidosis differential dosing dpp4 em endo fungal glp1
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS) Absolute Insulin deficit: - Type I DM:
Pathophysiology ... Hyperosmolar Syndrome (HHS ... Polydipsia #dka #hhs ... #pathophysiology ... #comparison #endocrinology
Mechanism of Action for Common Diabetes Medications • SGLT2i (Dapagliflozin) • TZD (Pioglitazone) • Biguanides (Metformin)
Action for Common Diabetes ... sarahthelyon #Diabetes ... #Medications #pharmacology ... #pathophysiology ... #endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... of medications has ... #pharmacology #pharmacotherapy ... #endocrinology
Pathyophysiology - hyperglycemic crises in patients with diabetes Key signs/symptoms of HHS/DKA: Both: Polyuria, polydipsia, weight loss,
Pathyophysiology ... patients with diabetes ... signs/symptoms of HHS ... Pathophys #EM #IM ... #Endo #DKA #HHS
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Insulin, Inhibits Glucagon ... food and inhibit glucagon ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Hypoglycemia Workup and Differential Diagnosis Workup: • Sulfonylurea Labs • Anti-lnsulin Ab - Insulin Autoimmune Syndrome •
Measure glucose q6 hrs ... symptomatic or 72+hrs ... - 1mg IV Glucagon ... , 20 & 30 mins later ... Diagnosis #insulinoma #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... pancreas (GLP-1 = Glucagon-like ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
Intranasal Glucagon (Baqsimi) The FDA has approved the first intranasal glucagon product! It's branded under the name
4 or older who has ... diabetes and has ... actually similar to IM ... reasons to use IM ... #Baqsimi #Pharmacology
Diabetic Ketoacidosis (DKA) - Pathogenesis and Clinical Findings • Note: in DKA, body K+ is lost
Diabetic Ketoacidosis ... ensure patient has ... DiabeticKetoacidosis #DKA #pathophysiology ... #endocrinology ... #diabetes
Anaphylaxis: Treatments (Acute) Additional Info: • IV steroids may be considered for prevention of late phase reactions.
prevention of late ... minimum of 4-6 hrs ... treatment) 1:1000 IM ... Treatments #Management #pathophysiology
No results found for "late pathophysiology im endocrinology diabetes hhs pharmacology glucagon"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #late #pathophysiology #im #endocrinology #diabetes #hhs #pharmacology #glucagon